Home › NCT03704207

Utility of PCD Diagnostics to Improve Clinical Care

Who can join

Ages 1 and older · All sexes

Inclusion Criteria:

* Referred to center for PCD diagnosis considerations
* Ability to perform study procedures
* Age greater than 2 years of age

Exclusion Criteria:

* Age less than 2 years of age Inability to perform informed consent

About the study

This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.

What is being tested

• nNO testing (other)

Sponsor: Vanderbilt University Medical Center · Participants: 200 · Started: Jun 1, 2017

Contact the study team

• Michael O'Connor, MD · Phone: 615.343.7617

Official record on ClinicalTrials.gov — NCT03704207

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.